v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:            
Net increase/(decrease) in net assets resulting from operations $ (2,204,074) $ 333,682 $ (4,408,913) $ 592,145 $ (3,814,243) $ 102,228
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:            
Repayments and sales of portfolio investments     20,354,403 12,924,933    
Purchases of investments     (5,696,509) (37,735,814)    
Net change in unrealized (gains)/losses on investments 2,658,325 34,438 4,643,399 (316,456)    
Net realized losses on investments 831,255 394,340 1,901,577 1,121,097    
Net realized losses on extinguishment of debt 0 0 495,849 0    
Net Reductions to Subordinated Structured Notes and related investment cost     179,940 387,267    
Payment-in-kind interest (113,465) (97,706) (145,021) (166,986)    
Amortization of premiums (accretion of purchase discounts) on investments, net     (139,621) (161,877)    
Amortization of deferred financing costs     127,154 210,055    
Amortization of offering costs     82,085 272,819    
Settlement of Treasury Bills     (342) (257)    
(Increase) Decrease in operating assets            
Due from Adviser (Note 4)     (282,615) 0    
Interest receivable     33,211 (302,410)    
Receivable for repayments of portfolio investments     (119,676) (99,949)    
Prepaid expenses and other assets     58,010 50,615    
Increase (Decrease) in operating liabilities            
Interest payable     86,236 (147,623)    
Accrued legal fees     (66,054) (203,880)    
Accrued audit fees     (41,250) 22,500    
Excise tax payable (Note 6)     26,328 0    
Accrued expenses     (23,669) (74,963)    
Payable for open trades     (340) (1,183)    
Due to Administrator (Note 5)     0 268,500    
Net cash provided by/(used in) operating activities     17,064,182 (23,361,467)    
Cash flows from financing activities:            
Gross proceeds from shares sold     0 10,010,400    
Distributions paid to stockholders     (215,781) (255,526)    
Repurchase of common stock     (514,121) (692,167)    
Borrowings under Senior Secured Revolving Credit Facility (Note 10)     3,400,000 36,900,000    
Repayments under Senior Secured Revolving Credit Facility (Note 10)     (48,900,000) (20,200,000)    
Borrowings under OZK Credit Facility (Note 10)     48,175,000 0    
Repayments under OZK Credit Facility (Note 10)     (11,134,268) 0    
Financing costs paid and deferred     (959,105) (19,201)    
Net cash provided by/(used in) financing activities     (10,148,275) 25,743,506    
Net increase (decrease) in Cash and Cash Equivalents     6,915,907 2,382,039    
Cash and Cash Equivalents at beginning of period     16,499,200 15,406,421 17,788,460  
Cash and Cash Equivalents at end of period $ 23,415,107 $ 17,788,460 23,415,107 17,788,460 $ 23,415,107 $ 17,788,460
Supplemental disclosures:            
Cash paid for interest     1,255,418 1,749,207    
Non-cash financing activities:            
Value of shares issued through reinvestment of distributions     $ 1,614,657 $ 1,362,153